Exelixis, Inc. (EXEL) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Exelixis, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.497 Good day, ladies and gentlemen, and welcome to the xAlexis First Quarter 2025 Financial 00:00:05.497 -- 00:00:11.404 Results Conference Call. My name is Tawanda, and I will be your operator for today. 00:00:11.404 -- 00:00:15.549 As a reminder, this call is being recorded for replay purposes. 00:00:15.549 -- 00:00:18.653 I would now like to turn the call over to your host for today, Ms. 00:00:18.653 -- 00:00:23.138 Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. 00:00:23.138 -- 00:00:24.980 Please proceed. 00:00:24.980 -- 00:00:30.220 Thank you, Tawanda, and thank you all for joining us for the xAlexis First Quarter 2025 00:00:30.220 -- 00:00:34.646 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our 00:00:34.646 -- 00:00:39.713 President and CEO, Chris Senner, our Chief Financial Officer, PJ Haley, our 00:00:39.713 -- 00:00:44.800 Executive Vice President of Commercial, Amy Peterson, our Chief Medical Officer, and 00:00:44.800 -- 00:00:49.307 Dana Aftab, our Chief Scientific Officer, who will review our progress for the first 00:00:49.307 -- 00:00:54.050 quarter 2025 and in March 31st, 2025. 00:00:54.133 -- 00:00:57.999 During the call today, we will refer to financial measures not calculated according to 00:00:57.999 -- 00:01:02.220 generally accepted accounting principles. Please refer to today's press release, which 00:01:02.220 -- 00:01:07.466 is posted on our website, for an explanation of our reasons for using such non-GAAP measures, 00:01:07.466 -- 00:01:11.171 as well as tables deriving these measures from our GAAP results. 00:01:11.171 -- 00:01:14.655 During the course of this presentation, we will be making forward-looking statements 00:01:14.655 -- 00:0...